Your browser doesn't support javascript.
loading
Recognition and management of complications of new recreational drug use.
Ricaurte, George A; McCann, Una D.
Afiliação
  • Ricaurte GA; Department of Neurology, Johns Hopkins University School of Medicine, Johns Hopkins Bayview Medical Center, Baltimore, MD, USA. Ricaurte@jhmi.edu
Lancet ; 365(9477): 2137-45, 2005.
Article em En | MEDLINE | ID: mdl-15964451
ABSTRACT
Use of illicit drugs in clubs and large dance parties (so-called raves) is a burgeoning cultural trend. Such recreational drug use is associated with several medical complications, both acute and longlasting. Although few, if any, of the drugs currently used in recreational venues are truly new, their patterns and context of use have changed (a great deal in some instances). For some of these substances, this cultural repackaging of the drug experience has resulted in various medical disorders that have previously gone undocumented. This review aims to help treating physicians recognise and manage complications associated with the use of new drugs in clubs, including methylenedioxymethamfetamine, ephedrine, gamma-hydroxybutyrate; gamma-butyrolactone, 1,4-butanediol, flunitrazepam, ketamine, and nitrites. We also alert researchers to specific toxic effects of club-drugs on which more basic information is needed.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Drogas Ilícitas / Transtornos Relacionados ao Uso de Substâncias Limite: Humans Idioma: En Ano de publicação: 2005 Tipo de documento: Article
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Drogas Ilícitas / Transtornos Relacionados ao Uso de Substâncias Limite: Humans Idioma: En Ano de publicação: 2005 Tipo de documento: Article